Newborn and Pediatric Health Services PA
Newborn and Pediatric Health Services PA was paid $3.01M by Medicaid between Mar 2019 and Dec 2024, across 54 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 15% of everything it billed.
33Billing provider infoNEWBORN AND PEDIATRIC HEALTH SERVICES PA
DALLAS, TX 75237
DALLAS, TX 75237
33aNPI1245355726assigned 03/21/2007
33bProvider typeSpecialist
28Total paid$3.01M
24GClaims141,275
24DCodes billed54
24AFirst – last monthMar 2019 – Dec 2024
Compared with peers
Next to other Specialist providers in Texas
Rank by total paid#16 of 382
Median peer was paid$29K
This provider vs. median104×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2019 | 55 | $415.52 | |
| 2020 | 5,593 | $102K | |
| 2021 | 38,005 | $734K | |
| 2022 | 37,779 | $902K | |
| 2023 | 33,610 | $721K | |
| 2024incomplete | 26,233 | $549K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 15% | 12,488 | 11,296 | $436K |
| 87428 | 14% | 6,791 | 6,235 | $415K | |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 13% | 4,894 | 4,822 | $379K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 12% | 4,906 | 4,402 | $360K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 8.8% | 3,278 | 3,223 | $265K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 7.8% | 2,708 | 2,656 | $236K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 7.5% | 22,042 | 10,689 | $224K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 7.2% | 4,355 | 4,170 | $217K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 2.8% | 4,348 | 4,166 | $85K |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | 2.7% | 2,125 | 2,009 | $82K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 2.4% | 5,420 | 5,093 | $72K |
| 92551 | 2.0% | 6,723 | 6,616 | $60K |
42 more codes
| 99381 | 1.8% | 764 | $55K | |
| 90461 | 1.5% | 22,918 | $46K | |
| 87807 | <1% | 2,466 | $25K | |
| 90671 | <1% | 343 | $9K | |
| 83655 | <1% | 882 | $9K | |
| 87276 | <1% | 952 | $7K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 521 | $6K |
| 87275 | <1% | 964 | $5K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 375 | $5K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 254 | $3K |
| 85018 | <1% | 1,085 | $2K | |
| 86328 | <1% | 29 | $1K | |
| 90697 | <1% | 1,132 | $872.65 | |
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 14 | $726.12 |
| 81003 | <1% | 297 | $567.79 | |
| H0033 | Oral medication administration, direct observation | <1% | 247 | $371.45 |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 112 | $317.20 |
| 90619 | <1% | 525 | $313.74 | |
| 90710 | <1% | 1,694 | $241.12 | |
| 90677 | <1% | 662 | $204.13 | |
| S0119 | Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) | <1% | 33 | $140.00 |
| J7510 | Prednisolone oral, per 5 mg | <1% | 109 | $89.25 |
| 99173 | <1% | 6,659 | $84.00 | |
| 90633 | <1% | 1,895 | $36.31 | |
| 36416 | <1% | 1,210 | $21.00 | |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 159 | $7.09 |
| 90686 | <1% | 2,932 | $3.00 | |
| 90621 | <1% | 653 | $0.99 | |
| 90734 | <1% | 456 | $0.51 | |
| 90715 | <1% | 292 | $0.31 | |
| 90670 | <1% | 2,662 | $0.20 | |
| 90680 | <1% | 2,564 | $0.20 | |
| 90648 | <1% | 682 | $0.14 | |
| 90723 | <1% | 670 | $0.14 | |
| 90651 | <1% | 866 | $0.12 | |
| 90380 | <1% | 63 | $0.04 | |
| G8598 | Aspirin or another antiplatelet therapy used | 0% | 117 | $0.00 |
| 90672 | 0% | 59 | $0.00 | |
| 90698 | 0% | 1,790 | $0.00 | |
| 90696 | 0% | 629 | $0.00 | |
| 90656 | 0% | 440 | $0.00 | |
| 90381 | 0% | 21 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialALI, ASHMEAD (OWNER)
| Provider | Location | Paid |
|---|---|---|
| Ashmead Ali M.D. PA | Dallas, TX | $467K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.